1. Verghese P, Jordan S. Polycystic Kidney Disease. Updated 13 August 2008. http://emedicine.medscape.com/article/983281-overview.
2. Bernstein J, Evan A, Gardner K. Human cystic kidney diseases: epithelial hyperplasia in the pathogenesis of cysts and tumors. Pediatric Nephrology 1987; 1: 393–96.
3. Pascal H, Ferlicot S, Massoud W et al. Prevalence of Renal Cell Carcinoma in Patients with Autosomal Dominant Polycystic Kidney Disease and Chronic Renal Failure. Urology 2009; 74: 631–5.
4. Masoumi A, Reed-Gitomer B, Kelleher C et al. Potential pharmacological interventions in polycystic kidney disease. Drugs 2007; 67: 2495–2510.
5. Sweeney W, Chen Y, Nakanishi K et al. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 2000; 57: 33–40.
6. Sweeney W, Akkubulut J, Mueller B et al. Chronic blockade of 20-HETE reduces polycystic kidney disease in orthologous rat model of ARPKD. Am J Physiol Renal Physiol 2009; 294: F575–F582.
7. Leiber B, Olbrich G. Die klinischen Syndrome. Urban & Schwarzenberg, München, 1990: 1, 2.